Prediction: 1 Value Stock That Will Be Worth More Than Palantir by the End of 2026

Palantir remains richly valued despite a recent 20% drawdown—trading at roughly a $400 billion market cap on under $4 billion of revenue and about $850 million of EBIT with a P/E near 391—leaving its price looking divorced from fundamentals. By contrast, Philip Morris International offers durable cash generation (about $10 billion free cash flow LTM, $13.5 billion EBIT), stable smokeable volumes (down just 1.3% YTD) and modest smokeables revenue growth (+1% YTD) while its faster-growing smoke-free brands (Zyn, IQOS, Veev) drove smoke-free net revenue up 16.1% YTD to 41% of sales and Zyn volumes rose 37% YoY; PMI trades at a much lower P/E (~28) and a $243 billion market cap. The piece argues this valuation disconnect makes Philip Morris a cheaper, more predictable earnings story and posits PMI could exceed Palantir’s market capitalization by the end of 2026, underscoring the risk that Palantir’s growth is already priced in.

Analysis

Palantir remains richly valued despite a recent 20% drawdown and a 1,700% gain since going public; the company trades at roughly $400 billion market capitalization on under $4 billion in revenue and about $850 million in EBIT, implying a P/E near 391 that the article describes as divorced from fundamentals. By contrast, Philip Morris International (PM) trades at about $243 billion, with a P/E of 28, roughly $13.5 billion in EBIT and approximately $10 billion in free cash flow over the last 12 months, establishing a clear earnings and cash-flow advantage.

Philip Morris's smokeables volumes have declined only 1.3% year-to-date while smokeables revenue rose 1% YTD, and its smoke-free portfolio is accelerating: smoke-free net revenue increased 16.1% YTD to 41% of net revenues and Zyn sold an estimated 205 million cans in the U.S. last quarter (+37% YoY). The article argues these trends make PM a durable cash generator and growth compounder as it shifts to smoke-free products, supporting the thesis that PM could surpass PLTR in market capitalization by the end of 2026 if markets re-rate fundamentals.

Sentiment and disclosure signals reinforce the narrative: per-ticker sentiment is negative for PLTR (-0.8) and positive for PM (+0.6), while the piece includes Motley Fool position disclosures that could bias framing; investors should therefore weigh the hard operating metrics (EBIT, FCF, revenue mix) over promotional language.

Key Decisions for Investors

• Trim or avoid initiating new long exposure to PLTR given a $400 billion market cap versus ~$850 million in EBIT and a P/E near 391, and if retaining exposure implement hedges or strict valuation-based sell triggers
• Consider adding or overweighting Philip Morris as a value/defensive holding because it generates roughly $10 billion FCF LTM, $13.5 billion EBIT, trades at a P/E of ~28, and shows accelerating smoke-free growth (smoke-free revenue +16.1% YTD, Zyn +37% YoY)
• Monitor KPIs closely—Palantir revenue and earnings trajectory and margin improvement, and Philip Morris smoke-free mix, Zyn unit growth, and smokeable volume trends (1.3% decline YTD)—and reassess allocations if these metrics diverge from the article's assumptions
• Account for potential outlet bias from disclosed positions and set a time-based reevaluation (for example end-2026) to test the article's market-cap crossover thesis rather than relying on a single narrative